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To stratify outcomes of trabectome-mediated ab interno trabeculectomy (AIT) by glaucoma
severity using a simple and clinically useful glaucoma index. Based on prior data of trabec-
tome after failed trabeculectomy, we hypothesized that more severe glaucoma might have
a relatively more reduced facility compared to mild glaucoma and respond with a larger IOP
reduction to trabecular meshwork ablation.
Methods
Patients with primary open angle glaucoma who had undergone AIT without any other
same session surgery and without any second eye surgery during the following 12 months
were analyzed. Eyes of patients that had less than 12 months follow up or were diagnosed
with neovascular glaucoma were excluded. A glaucoma index (GI) was created to capture
glaucoma severity based on visual field, number of preoperative medications, and preoper-
ative IOP. Visual field (VF) was separated into 3 categories: mild, moderate, and advanced
(assigned 1, 2, and 3 points, respectively). Preoperative number of medications (meds) was
divided into 4 categories:1, 2, 3 or4, and assigned with a value of 1 to 4. Baseline IOP
(IOP) was divided into 3 categories: <20 mmHg, 20–29 mmHg, and greater than 30 mmHg
and assigned with 1 to 3 points. GI was defined as IOP × meds × VF and separated into 4
groups: <6 (Group 1), 6–12 (Group 2), >12–18 (Group 3) and >18 (Group 4). Linear regres-
sion was used to determine if there was an association between GI group and IOP reduction
after one year or age, gender, race, diagnosis, cup to disc (C/D) ratio, and Shaffer grade.
Results
Out of 1340 patients, 843 were included in the analysis. The GI group distribution was GI1 =
164, GI2 = 202, GI3 = 260, and GI4 = 216. Mean IOP reduction after one year was 4.0±5.4,
6.4±5.8, 9.0±7.6, 12.0±8.0 mmHg for GI groups 1 to 4, respectively. Linear regression
showed that IOP reduction was associated with GI group after adjusting for age, gender,
race, diagnosis, cup to disc ratio, and Shaffer grade. Each GI group increase of 1 was
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associated with incremental IOP reductions of 2.95±0.29 mmHg. Success rate at 12 months
was 90%, 77%, 77%, and 71% for GI groups 1 to 4. The log-rank test suggested significant
differences between GI groups.
Conclusion
A simple glaucoma index, GI, was created to capture glaucoma severity and a relative resis-
tance to treatment. A higher GI was associated with a larger IOP reduction in trabectome
surgery. This indicates that there is a role for AIT beyond mild glaucoma and ocular
hypertension.
Introduction
The trabecular meshwork (TM) is the primary site of outflow resistance in open angle glaucoma
[1]. Plasma-mediated ablation of this tissue in ab interno trabeculectomy (AIT) using the trabec-
tome increases outflow facility in different types of glaucomas [2–4]. We hypothesized that an
eye with a more diseased trabecular meshwork has a higher outflow resistance and might there-
fore experience a larger intraocular pressure (IOP) reduction than one with only a mild outflow
resistance. The preoperative number of medications and visual field status might similarly reflect
the severity of trabecular meshwork disease and its resistance in open angle glaucoma. A previous
study suggested that patients with a failed trabeculectomy and advanced visual field damage had
a larger IOP decrease from trabectome surgery than patients with a less advanced visual field loss
but these differences were not statistically significant due to sample size [5].
In the present study we created a simple glaucoma index that combines preoperative IOP,
number of preoperative medications and visual field damage to capture relative glaucoma
severity and resistance to treatment. This index was used to compare outcomes of AIT strati-
fied by glaucoma index.
Methods
Data for this study were analyzed with approval by the Institutional Review Board of the Uni-
versity of Pittsburgh, in accordance with the Declaration of Helsinki and the Health Insurance
Portability and Accountability Act. No informed consent was necessary for this retrospective,
observational cohort study. Patient records were anonymized and de-identified prior to analy-
sis. The specific target IOP was set on a case-by-case basis by the individual treating physician
and the maximum IOP was estimated to prevent further nerve damage. Patients who were fol-
lowed for less than 12 months or diagnosed with neovascular glaucoma were excluded. Indica-
tions for AIT consisted of worsening glaucoma on maximally tolerated topical therapy.
Anterior chamber angles in all patients were graded by Shaffer grade (SG) [3,6], a classification
system in which ‘0’ to ‘slit’ represents a totally or partially closed angle with potential for angle
closure that is present or very likely, ‘1’ an angle width of 10° (very narrow) and closure poten-
tial that is probable, ‘2’ representing 20° and possible potential for closure, ‘3’ standing for 20°
to 45° with unlikely closure and grade ‘4’ indicating a wide open angle and improbable poten-
tial for angle closure.
The glaucoma index, GI, was created as a variable based on visual field, number of preopera-
tive medications, and preoperative IOP. Visual field was separated into 4 categories: up to
mild, up to moderate, up to advanced, and more than advanced visual field damage [7], which
were assigned 1, 2, 3 and 4 points, respectively. Preoperative number of medications were
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divided into 4 categories: 0–1, 2, 3 or 4+, and assigned with a value of 1 to 4, respectively. Base-
line IOP was divided into 3 categories: <20 mmHg, 20–29 mmHg, 30–39 mmHg, and greater
than 40 mmHg and assigned with 1 to 4 points, respectively. These categories were chosen
based on IOP distribution and designed not to underrate low pressure glaucoma. GI was then
defined as preoperative IOP × preoperative number of medications × VF. GI was separated
into 4 groups:<6 (Group 1), 6–12 (Group 2),>12–18 (Group 3) and>18 (Group 4). A power
calculation indicated that 82 patients would allow to detect a GI group IOP difference or 3
mmHg for a medium-sized effect of 0.3 with a power of 80%. Linear regression was used to
determine if there was an association between GI group and IOP reduction after one year. An
identical analysis was performed only for patients with primary open angle glaucoma.
Baseline characteristics were compared by the Kruskal-Wallis and chi square tests for con-
tinuous and categorical variables between GI groups, respectively. Univariate linear regression
was performed first and those variables that were found to be statistically significant were
included into multivariate regression. The term “success rate” was used here instead of the sta-
tistics term “survival” and defined as IOP21 mmHg, at least 20% IOP reduction from baseline
in any two consecutive visits after three months, and no secondary glaucoma or lens surgery.
Log-rank test was used to compare success distributions of GI groups. Continuous data was
reported as mean ± standard deviation.
Fig 1. Distribution of Glaucoma Index Variables. A) Visual field score distribution included a relatively
large number of eyes with advanced visual field damage. B) Three medications was the most common
median number of eye drops used. C) Most patients had a preoperative intraocular pressure in the range of
20 to 29 mmHg.
doi:10.1371/journal.pone.0151926.g001
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Results
A total of 842 eyes were analyzed. The average age of all patients was 66.4±15.8 years. Variables
used to compute GI were 1) preoperative IOP, 2) preoperative number of medications and 3)
visual field status. The average preoperative IOP for all patients was 25.1±6.7 mmHg, the aver-
age medication count was 2.9±1.0 and the most common visual field was advanced. The base-
line IOP categories were chosen as described above because of the distribution (Fig 1).
Table 1. Demographics and Biometrical Data.
GI Group 1 (n = 164) GI Group 2(n = 202) GI Group 3(n = 260) GI Group 4(n = 216) p-value
Age 0.26
Mean±SD 69±12 66±14 67±17 64±19
Range 36–92 18–88 18–96 18–96
Gender <0.01
Female 102 (62%) 117 (58%) 123 (47%) 99 (46%)
Male 59 (36%) 84 (42%) 136 (52%) 109 (50%)
NR 3 (2%) 1 (0%) 1 (0%) 8 (4%)
Ethnicity <0.01
African American 15 (9%) 10 (5%) 15 (6%) 11 (5%)
Asian 26 (16%) 47 (23%) 74 (28%) 76 (35%)
Caucasian 93 (57%) 114 (56%) 146 (56%) 97 (45%)
Hispanic 22 (13%) 15 (7%) 14 (5%) 19 (9%)
Other 8 (5%) 16 (8%) 11 (4%) 13 (6%)
Diagnosis <0.01
POAG 136 (83%) 154 (76%) 177 (68%) 136 (63%)
Pseudoexfoliation 10 (6%) 20 (10%) 39 (15%) 29 (13%)
Pigment Dispersion 9 (5%) 7 (3%) 8 (3%) 5 (2%)
Steroid Induced 3 (2%) 12 (6%) 24 (9%) 34 (16%)
Others 6 (4%) 9 (4%) 12 (5%) 12 (6%)
VA (logMar) <0.01
Mean±SD 0.23±0.34 0.24±0.36 0.32±0.53 0.44±0.58
Range -0.18–2.12 -0.19–2.00 -0.19–3.00 -0.19–3.00
Disc C/D <0.01
Mean±SD 0.69±0.16 0.75±0.15 0.73±0.18 0.83±0.11
Range 0.1–0.95 0.3–1.0 0.1–1.0 0.3–1.0
Lens Status 0.05
Phakic 95 (58%) 115 (57%) 132 (51%) 96 (44%)
Pseudophakic 54 (33%) 77 (38%) 114 (44%) 103 (48%)
Aphakic 1 (1%) 1 (0%) 0 (0%) 3 (1%)
NR 14 (9%) 9 (4%) 14 (5%) 14 (6%)
Shaffer Grade 0.16
I 1 (1%) 6 (3%) 3 (1%) 1 (0%)
II 9 (5%) 10 (5%) 14 (5%) 16 (7%)
III 42 (26%) 58 (29%) 80 (31%) 69 (32%)
IV 99 (60%) 97 (48%) 131 (50%) 103 (48%)
NR 13 (8%) 31 (15%) 32 (12%) 27 (12%)
GI1: GI<6, GI2: 6GI<12, GI3: 12GI<18, GI4: GI18
doi:10.1371/journal.pone.0151926.t001
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Only 22 eyes had an IOP above 40 mmHg and had to be excluded because of an insufficient
power to contribute to a separate group. There was no significant age difference among GI
groups (Table 1).
GI1 had a significantly lower portion of male patients while the other groups were more
gender balanced. Most patients were Caucasians followed by Asians and then by Hispanics and
Fig 2. IOP reduction at one year by glaucoma index. Patients with a higher glaucoma index (GI) had a
larger absolute reduction of intraocular pressure (IOP).
doi:10.1371/journal.pone.0151926.g002
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African Americans at comparable percentages. Seventy-one percent had the diagnosis of pri-
mary open angle glaucoma which was more common in GI1. Steroid induced glaucoma
increased in frequency from GI1 to GI4 eightfold. Visual acuity decreased from GI1 to GI4 to
approximately half of that of GI1. The cup to disc (C/D) ratio increased significantly by glau-
coma severity index from 0.69 to 0.83. There were more pseudophakic eyes in GI4 compared
to the other groups and most of the phakic eyes were found in GI1 (p = 0.05). There were no
significant differences in distribution of degree of angle opening among GI groups and approx-
imately 80% of eyes had a Shaffer grade above 2 indicating a wide open angle.
Mean IOP reduction at one year was 4.0±5.4, 6.4±5.8, 9.0±7.6, 12.0±8.0 mmHg for GI
groups 1 to 4, respectively (Fig 2), with significant intergroup differences (p<0.05). There was
a larger range of IOP reduction in higher groups.
A higher preoperative IOP was associated with a higher GI group assignment but the post-
operative IOPs were not significantly different at any visit and often indistinguishable (Fig 3).
Similarly, the higher the GI group assignment, the higher the preoperative medication
count (Fig 4). The higher GI groups, GI4 and GI3, had a significantly lower average medication
count at 6 and 12 months.
Patients with moderate visual field damage had a slightly higher average preoperative and
day 1 IOP compared to patients with mild or advanced visual field loss (Fig 5). Differences
were not significant thereafter (p>0.05). Compared to GI2 through GI4, GI1 had a better suc-
cess rate of 90%, the highest of all groups (Fig 6). This was followed by GI2 and GI3 with 77%
followed closely by GI4 with 71%.
Fig 3. Individual IOPs by glaucoma index (GI). A higher GI was associated with a higher preoperative IOP while postoperative IOPs were similar (table:
mean±SD).
doi:10.1371/journal.pone.0151926.g003
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Univariate linear regression (Table 2), which was performed first, identified age, male gen-
der, Hispanic ethnicity, diagnosis of pseudoexfoliation and steroid induced glaucoma, and C/D
ratio to be most significant. These were included in the multivariate regression.
In the multivariate regression analysis (Table 3), GI group, age, Hispanic ethnicity, steroid
induced glaucoma, and C/D ratio were found to be significantly associated with IOP reduction. For
patients that differ in GI groups by 1, patients in the higher GI group are expected to have a further
incremental IOP reduction of 2.95±0.29 mmHg than patients in the next lower GI group. Success
rate at 12 months was 90%, 77%, 77%, and 71% for GI groups 1 to 4. Log-rank test indicated a sta-
tistically significant success rate difference between GI groups. Patients in lower GI groups had a
higher success rate than those in higher GI groups. The regression analysis had a power of 0.95.
The analogous analysis of the above of only primary open angle glaucoma patients indicated
a similar greater IOP reduction of IOP with higher GI group (Fig 3B). We also determined the
relative IOP reduction as a function of preoperative IOP (S1 Fig). In analogy to the absolute
reduction, the percentage decrease was the larger the higher the group index.
The results of the multivariate analysis for POAG only (Table 4) also found GI group to be
associated with IOP reduction in a similar fashion as all patients (Table 3). After adjusting for
gender, race and cup-to-disc ratio, cases in one GI group higher had an extra 2.98±0.28 mmHg
reduction in IOP than those in one GI group lower. Males experienced an additional 1.32
mmHg IOP reduction compared to females with the same GI group, race and C/D. Hispanics
Fig 4. Mean number of medications by GI.While there was an overall decrease in the number of medications in all groups, GI3 and GI4 showed the most
significant changes (p<0.05) after 6 months postoperatively.
doi:10.1371/journal.pone.0151926.g004
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had a greater IOP reduction of 4.18 mmHg when compared to African Americans after adjust-
ing for all other variables. Patients with a higher C/D experienced a lesser IOP decrease than
those with lower C/D after adjusting for GI group, gender and race.
Discussion
Despite recent efforts [8] to incorporate glaucoma severity into clinical practice to include
treatment guidelines and outcome measures [9], most staging systems only consider visual
field function [7], optic nerve damage [10] or a combination of visual field and retinal nerve
fiber layer loss [11]. Richardson described an early system to combine treatment goals and
modalities as well as functional damage into a glaucoma stage [12]. Because few topical glau-
coma medications existed at that time, the number of topical medications was not a useful
measure to gauge resistance to treatment and relate this to surgical success. Reduction of medi-
cation is now commonly used as a primary outcomes measure that is reported together with
IOP, both in traditional glaucoma surgery [13] and in micro-incisional glaucoma surgeries
[3,14]. A stratification of glaucoma surgical outcomes by glaucoma severity has not been for-
mally examined and published. This study fills an important knowledge gap in by providing
this data for a form of modern glaucoma surgery that is minimally invasive and has a consider-
ably better safety profile [4].
The goal of this study was to examine whether clinical open angle glaucoma severity, as cap-
tured by a simple glaucoma index, is correlated to IOP reduction. Glaucoma with a high IOP
despite several anti-glaucoma medications and worsening visual field may indicate a high treat-
ment resistance or, more specifically, a highly reduced outflow facility. We hypothesized that
eyes with a higher glaucoma index would show a larger IOP reduction following TM ablation
Fig 5. Intraocular pressure by visual field.While patients with moderate visual field loss had slightly higher IOPs prior to surgery, they were not different
after day 1.
doi:10.1371/journal.pone.0151926.g005
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compared to eyes with less severe outflow resistance. This is indeed the case and consistent
with the consensus that the TM is the site of the highest outflow resistance in most open angle
glaucomas. While postoperative IOPs were highly similar in all GI groups, the most severe
groups also experienced the largest reduction in medications. Such behavior is predicted by the
Goldmann equation (IOP = F/C + Pv—U (aqueous humor formation/facility + episcleral
venous pressure—uveoscleral outflow)) because a large facility “C” (TM is absent) will result in
a very small “F/C” so that IOP is only limited by the episcleral venous pressure and uveoscleral
outflow. Consistent with this, two studies have reported a surprisingly high success rate of tra-
bectome surgery after failed tube shunts [15] and after failed trabeculectomy [5].
As could be expected, GI1, indicative of mild glaucoma, had the best success of all groups.
Interestingly, the remaining GI2 and 3 had an almost identical success course and GI4 was
only slightly worse. The success rate observed here is very similar to that of other studies
[16,17] or better [18]. This suggests that greater glaucoma severity may be associated with an
increase in surgical failure rates.
The data presented here matches established glaucoma risk factors and provides some vali-
dation: GI1 had disproportionately more female patients. This may reflect the preponderance
of women among patients with low pressure glaucoma [19,20]. Pseudoexfoliation and steroid
induced glaucoma may be found more commonly in this population because of a relatively
Fig 6. Success plot by glaucoma index. Subjects in GI1 had the best success while GI2 through GI4 were not significantly different.
doi:10.1371/journal.pone.0151926.g006
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Table 2. Univariate Regression.
Coefﬁcient Standard Error p-value
Age -0.07 0.02 <0.01
Male 1.55 0.58 <0.01
Ethnicity
Asian 0.89 1.29 0.49
Caucasian 1.25 1.28 0.33
Hispanic 4.44 1.62 <0.01
Other 0.37 1.66 0.82
Diagnosis
Other 2.45 1.44 0.09
Pseudoexfoliation Glaucoma 2.75 0.94 <0.01
Pigmentary Dispersion 1.61 1.82 0.37
Steroid Induced 5.77 1.17 <0.01
C/D Ratio -5.94 2.07 <0.01
Shaffer Grade -1.87 1.16 0.17
Lens
Aphakic -2.42 3.81 0.53
Pseudophakic -1.42 0.76 0.08
doi:10.1371/journal.pone.0151926.t002
Table 3. Multivariate Regression for All Open Angle Glaucomas.
Coefﬁcient Standard Error p-value
GI group 3.02 0.30 <0.01
Age -0.05 0.02 0.01
Male 0.52 0.55 0.35
Ethnicity
Asian -1.20 1.17 0.31
Caucasian 1.21 1.19 0.31
Hispanic 4.33 1.49 < 0.01
Other 0.06 1.46 0.97
Diagnosis
Other 1.84 1.37 0.18
Pigmentary Dispersion 0.40 1.73 0.82
Pseudoexfoliative Glaucoma 1.78 0.92 0.06
Steroid Induced 3.37 1.32 0.02
C/D Ratio -9.79 2.06 <0.01
doi:10.1371/journal.pone.0151926.t003
Table 4. Multivariate Regression for Primary Open Angle Glaucoma.
Coefﬁcients Standard Error p-value
GI group 2.98 0.26 <0.01
Male 1.32 0.60 0.03
Race
Asian -0.88 1.12 0.43
Caucasian 0.64 1.06 0.54
Hispanic 4.18 1.45 <0.01
Other -1.20 1.62 0.46
C/D -11.74 1.99 <0.01
doi:10.1371/journal.pone.0151926.t004
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more severe course either by damage or IOP, moving these forms of secondary open angle
glaucoma into the higher GI groups. Patients with pseudoexfoliation typically have a larger
IOP reduction after trabectome surgery [2] which may have contributed to the observed group
behavior of a better pressure decrease in those groups in our study. GI4 had a significantly
worse visual acuity than other groups which may be a result of commonly coinciding cataracts
[21] that are still present in some of these patients but also with loss of visual acuity from glau-
coma damage in advanced visual field loss. The later appears to be reflected in the significantly
larger C/D ratio in GI4, the results of more advanced structural damage. Both regression analy-
ses are reflective of the demographic and biometric observations and also point to Hispanic
ethnicity as a group that is at an increased risk [22].
Limitations of this study are the use of categorical rather than continuous data for baseline
IOP and a simplified stratification of glaucoma severity. We did this to avoid progressive
underrating of glaucoma severity in the low pressure glaucoma range when raw data was used.
The relatively large number of patients analyzed here and equal group sizes allowed to apply
meaningful and valid statistical methods. Another shortcoming is that this study is retrospec-
tive in nature and may include bias for procedure selection. This is partially countered by rela-
tively even patient numbers in all groups.
A recent study indicated that there is a tipping point during the course of glaucoma suggest-
ing that more severe glaucoma may require more aggressive pressure lowering [23]. In this
context, while this study can guide glaucoma surgeons to avoid risks inherent in traditional
glaucoma surgeries, it is important to keep in mind that lowering intraocular pressure is a life-
long commitment to manage an often relentless and progressive disease. A minimally invasive
surgery may only be the initial step.
Supporting Information
S1 Fig. IOP reduction at 1 year as percentage of preoperative IOP. A) In all open angle glau-
coma patients, a higher glaucoma index group assignment indicating more severe glaucoma
was found to be associated with a larger IOP reduction (percentage +/- 95% confidence inter-
val). B) Primary open angle glaucoma had highly similar IOP percentage reduction at 1 year
(percentage +/- 95% confidence interval).
(PDF)
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